Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Insider Selling: Hims & Hers Health (NYSE:HIMS) Insider Sells $367,870.91 in Stock
06:06am, Sunday, 21'st Dec 2025
Hims and Hers Health, Inc. (NYSE: HIMS - Get Free Report) insider Patrick Harrison Carroll sold 10,021 shares of the stock in a transaction that occurred on Wednesday, December 17th. The stock was sol
Hims & Hers Health (NYSE:HIMS) Insider Sells $308,767.81 in Stock
06:06am, Sunday, 21'st Dec 2025
Hims and Hers Health, Inc. (NYSE: HIMS - Get Free Report) insider Irene Becklund sold 8,411 shares of the stock in a transaction on Wednesday, December 17th. The shares were sold at an average price o
These 5 Stocks Are Set To Dominate 2026
12:49pm, Friday, 19'th Dec 2025
My 2025 picks outperformed the S&P 500 by 9.4% and Nasdaq 100 by 5.9%, validating my growth-value approach. Each stock on this list is operating in a different market segment and two are based in Euro
2 Top Stocks to Buy With $500 Right Now
08:31am, Friday, 19'th Dec 2025
Amazon's cost-cutting could supercharge its profitability. Hims & Hers has explosive long-term growth potential.
3 Skyrocketing MedTech Stocks That Might Lose Steam in 2026
10:11am, Thursday, 18'th Dec 2025
Here are some surging MedTech stocks - GMED, TMDX and HIMS - that may face slowing momentum in 2026.
Hims & Hers Scales Technology-Driven Care as Profitability Evolves
01:16pm, Tuesday, 16'th Dec 2025
HIMS scales personalized care, expands globally and invests in technology as it balances growth with evolving profitability.
Hims & Hers Expands Weight-Management Program to the United Kingdom
10:41am, Friday, 12'th Dec 2025
HIMS expands its Weight Loss Program to the United Kingdom, bringing personalized, doctor-designed care and broader access to obesity treatments.
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
10:01am, Friday, 12'th Dec 2025
Recently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care
11:36am, Thursday, 11'th Dec 2025
HIMS expands its tech-driven care with new diagnostics, hormonal treatments, and a Canada launch via Livewell.
Hims & Hers Expands Weight Loss Program to the U.K.
06:34am, Wednesday, 10'th Dec 2025
Hims and Hers (HIMS, Financials) is taking another step in its push into weight-management care, bringing its popular program to customers in the U.K. For those w
Hims and Hers to offer weight-loss treatments in UK
03:36am, Wednesday, 10'th Dec 2025
Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United Kingdom which will include drugs like Novo Nordisk's Wegovy, the company said o
Hims & Hers Brings Comprehensive Weight Loss Programme to the UK
03:30am, Wednesday, 10'th Dec 2025
LONDON--(BUSINESS WIRE)--Hims & Hers is deepening its commitment to the UK by bringing access to its comprehensive Weight Loss Programme to customers. This expansion includes the official introduction
Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell?
12:25pm, Tuesday, 09'th Dec 2025
HIMS expands into Canada and Europe while facing regulatory hurdles and execution risks in weight-loss care.
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?
12:41pm, Monday, 08'th Dec 2025
Investors interested in Medical Info Systems stocks are likely familiar with Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors with the better value
Hims & Hers: The Market's Panic Is Irrational
04:39am, Sunday, 07'th Dec 2025
Hims & Hers Health has sold off ~40% GLP-1 turbulence, but the core growth story remains intact. The company is building a moat through personalized medicine, vertical integration, and diversification
